文献速递脑血管病

临床近似低灌注组织体积在大血管闭塞性卒中中的应用

Clinically Approximated Hypoperfused Tissue in Large Vessel Occlusion Stroke.
PubMed 文献 · Stroke · 2021-05-11

本研究回顾性分析3个中心309例前循环大血管闭塞卒中患者,推导出基于NIHSS评分的转换因子(NIHSS<10用15,≥10用6)估算低灌注组织体积(CAT)。在验证队列中,CAT标准识别DEFUSE-3合格患者的敏感度100%、特异度92%(AUC 0.92,95%CI 0.82–1)。

要点

  • NIHSS<10时转换因子为15,≥10时为6,用于估算低灌注体积。
  • CAT标准识别DEFUSE-3合格患者敏感度100%、特异度92%。
  • 该方法或可简化延迟时间窗取栓筛选,但需进一步验证。

核心结论

  • 基于NIHSS评分的转换因子可估算大血管闭塞卒中的低灌注组织体积,并准确识别DEFUSE-3合格患者。

研究设计与样本

  • 回顾性分析3个综合卒中中心的前循环大血管闭塞卒中患者,共309例(年龄70±14岁,46%男性,中位NIHSS 16[12–20])。
  • 推导队列(中心A,187例)用于得出转换因子,验证队列(中心B和C,122例)用于测试CAT标准的准确性。
  • 以DEFUSE-3标准作为金标准,比较CAT体积(替代Tmax>6秒体积)的筛选效能。

主要发现

  • 38%的患者到达时间超过最后已知正常时间6小时。
  • 推导出的转换因子:NIHSS<10亚组为15,NIHSS≥10亚组为6(基于Tmax>6秒体积中位数)。
  • 验证队列中CAT标准识别DEFUSE-3合格患者的敏感度100%、特异度92%,AUC 0.92(95%CI 0.82–1)。

关键数值与推荐

  • CAT体积计算:NIHSS<10时乘以15,NIHSS≥10时乘以6。
  • CAT标准替代DEFUSE-3中的Tmax>6秒体积标准,敏感度100%、特异度92%。

临床怎么用

  • 在缺乏高级影像处理软件的延迟时间窗(>6小时),可用NIHSS评分快速估算低灌注体积以筛选取栓候选者。
  • NIHSS<10和≥10患者分别采用不同转换因子,有助于提高筛选准确性。

局限性

  • 回顾性研究设计,样本来自3个中心,外部推广性需进一步验证。
  • 转换因子基于中位数推导,可能不适用于所有个体。
  • 未报告对其他时间窗或不同血管闭塞部位的适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Patient selection for thrombectomy of acute ischemic stroke caused by large vessel occlusion in the delayed time window (>6 hours) is dependent on delineation of clinical-core mismatch or radiological target mismatch using perfusion imaging. Selection paradigms not involving advanced imaging and software processing may reduce time to treatment and broaden eligibility. We aim to develop a conversion factor to approximately determine the volume of hypoperfused tissue using the National Institutes of Health Stroke Scale (NIHSS) score (clinically approximated hypoperfused tissue [CAT] volume) and explore its ability to identify patients eligible for thrombectomy in the late-time window. METHODS: We performed a retrospective analysis of anterior circulation large vessel occlusion strokes at 3 comprehensive stroke centers. Demographic, clinical, and imaging (computed tomography perfusion processed using RAPID, IschemaView) information was analyzed. A conversion factor, which is a multiple of the NIHSS score (for NIHSS score <10 and ≥10), was derived from an initial cohort to calculate CAT volumes. Accuracy of CAT-based thrombectomy eligibility criteria (using CAT volume instead of Tmax >6 seconds volume) was tested using DEFUSE-3 criteria (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3) eligibility as a gold standard in an independent cohort. RESULTS: Of the 309 large vessel occlusion strokes (age, 70±14, 46% male, median NIHSS 16 [12–20]) included in this study, 38% of patients arrived beyond 6 hours of time from last known well. Conversion factors derived (derivation cohort-center A: 187) based on median values of Tmax>6 second volume for NIHSS score <10 subgroup was 15 and for NIHSS score ≥10 subgroup was 6. Subsequently calculated CAT volume–based eligibility criteria yielded a sensitivity of 100% and specificity of 92% in detecting DEFUSE-3 eligible patients (area under the curve, 0.92 [95% CI, 0.82–1]) in the validation cohort (center B and C:122). CONCLUSIONS: Clinical severity of stroke (NIHSS score) may be used to calculate the volume of hypoperfused tissue during large vessel occlusion stroke. CAT volumes for NIHSS score <10 (using a factor of 15) and ≥10 (using a factor of 6) subgroups can accurately identify DEFUSE-3-eligible patients.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Desai SM, Ortega-Gutierrez S, Sheth SA, et al. Clinically Approximated Hypoperfused Tissue in Large Vessel Occlusion Stroke. Stroke. 2021. PMID: 33971743. doi:10.1161/STROKEAHA.120.033294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。